WO2020055360A3 - The parenteral composition comprising carfilzomib - Google Patents

The parenteral composition comprising carfilzomib Download PDF

Info

Publication number
WO2020055360A3
WO2020055360A3 PCT/TR2019/050580 TR2019050580W WO2020055360A3 WO 2020055360 A3 WO2020055360 A3 WO 2020055360A3 TR 2019050580 W TR2019050580 W TR 2019050580W WO 2020055360 A3 WO2020055360 A3 WO 2020055360A3
Authority
WO
WIPO (PCT)
Prior art keywords
carfilzomib
parenteral composition
composition
parenteral
furthermore
Prior art date
Application number
PCT/TR2019/050580
Other languages
French (fr)
Other versions
WO2020055360A2 (en
Inventor
Ali Turkyilmaz
Irem Yenice
Ali Ihsan SECKIN
Yuksel TOPALOGLU
Original Assignee
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of WO2020055360A2 publication Critical patent/WO2020055360A2/en
Publication of WO2020055360A3 publication Critical patent/WO2020055360A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Abstract

The present invention relates to a parenteral composition comprising carfilzomib or a pharmaceutically acceptable salt thereof. Furthermore, the composition is obtained using an effective process.
PCT/TR2019/050580 2018-08-10 2019-07-16 The parenteral composition comprising carfilzomib WO2020055360A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201811693 2018-08-10
TR2018/11693 2018-08-10

Publications (2)

Publication Number Publication Date
WO2020055360A2 WO2020055360A2 (en) 2020-03-19
WO2020055360A3 true WO2020055360A3 (en) 2020-06-04

Family

ID=69777254

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050580 WO2020055360A2 (en) 2018-08-10 2019-07-16 The parenteral composition comprising carfilzomib

Country Status (1)

Country Link
WO (1) WO2020055360A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162352A1 (en) * 2007-12-21 2009-06-25 Michael Adler Antibody formulation
WO2016116882A2 (en) * 2015-01-23 2016-07-28 Leiutis Pharmaceuticals Pvt Ltd Novel compositions of carfilzomib
US20180117054A1 (en) * 2016-10-29 2018-05-03 Cipla Limited Stable carfilzomib formulations
WO2018138556A1 (en) * 2017-01-24 2018-08-02 Orbicular Pharmaceutical Technologies Pvt. Ltd. Non-aqueous carfilzomib compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162352A1 (en) * 2007-12-21 2009-06-25 Michael Adler Antibody formulation
WO2016116882A2 (en) * 2015-01-23 2016-07-28 Leiutis Pharmaceuticals Pvt Ltd Novel compositions of carfilzomib
US20180117054A1 (en) * 2016-10-29 2018-05-03 Cipla Limited Stable carfilzomib formulations
WO2018138556A1 (en) * 2017-01-24 2018-08-02 Orbicular Pharmaceutical Technologies Pvt. Ltd. Non-aqueous carfilzomib compositions

Also Published As

Publication number Publication date
WO2020055360A2 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
WO2016044446A3 (en) Sgc stimulators
WO2016159577A3 (en) 1,2-naphthoquinone derivative and method for preparing same
WO2019178191A8 (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors
WO2016044445A3 (en) sGC STIMULATORS
WO2017160116A3 (en) Novel compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
CA3139411A1 (en) Novel peptide compound or pharmaceutically acceptable salt thereof
WO2016125191A3 (en) Processes for the preparation of vortioxetine hydrobromide
WO2016038542A3 (en) Solid forms of sofosbuvir
WO2019150219A3 (en) Oxadiazoles for use in controlling phytopathogenic fungi
CA3048452C (en) Processes for preparing glycoprotein-drug conjugates
WO2015068175A3 (en) An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
WO2016159576A3 (en) 1,2-naphthoquinone derivative and method for preparing same
WO2017168447A9 (en) A cyclic compounds and process for the preparation thereof
WO2019078653A3 (en) Modified conjugated diene-based polymer and method for preparing same
PH12018500999A1 (en) Sodium channel blocker
WO2016027283A3 (en) A process for preparing indacaterol and salts thereof
WO2020046059A3 (en) Method for inhibiting dust generation, soil stabilizer composition, and spray device comprising same
WO2020055360A3 (en) The parenteral composition comprising carfilzomib
WO2019109067A3 (en) Creatine prodrugs, compositions and methods of use thereof
MX2016013439A (en) Solid forms of a pharmaceutically active compound.
WO2017214423A8 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
WO2017184670A3 (en) Methods for treating zika virus infections
WO2021107514A3 (en) Method for preparing lifitegrast
WO2017191619A3 (en) A process for the preparation of a salt of sacubitril and valsartan
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19860518

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19860518

Country of ref document: EP

Kind code of ref document: A2